Literature DB >> 6861872

Pharmacokinetics of biliary excretion in man V. Dibromosulfophthalein.

D K Meijer, J G Weitering, G A Vermeer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6861872     DOI： 10.1007/bf00609902

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  20 in total

1.  PHENOL 3, 6 DIBROMPHTHALEIN DISULFONATE, A NEW COMPOUND FOR THE STUDY OF LIVER DISEASE.

Authors:  N B JAVITT
Journal:  Proc Soc Exp Biol Med       Date:  1964-10

2.  Hepatic uptake and biliary excretion of dibromosulphthalein. Albumin dependence, influence of phenobarbital and nafenopin pretreatment and the role of y and z protein.

Authors:  D K Meijer; R J Vonk; K Keulemans; J G Weitering
Journal:  J Pharmacol Exp Ther       Date:  1977-07       Impact factor: 4.030

3.  Dibromsulphalein (DBSP) estimation of hepatic transport function in man.

Authors:  D Dhumeaux; P Berthelot; N B Javitt
Journal:  Eur J Clin Invest       Date:  1974-06       Impact factor: 4.686

4.  Hepatic handling of unconjugated dyes in the Dubin-Johnson syndrome.

Authors:  S Erlinger; D Dhumeaux; J F Desjeux; J P Benhamou
Journal:  Gastroenterology       Date:  1973-01       Impact factor: 22.682

5.  The fate of pancuronium bromide in man.

Authors:  S Agoston; G A Vermeer; U W Kertsten; D K Meijer
Journal:  Acta Anaesthesiol Scand       Date:  1973       Impact factor: 2.105

6.  The excretion of hexafluorenium in man and rat.

Authors:  D K Meijer; G A Vermeer; G Kwant
Journal:  Eur J Pharmacol       Date:  1971-05       Impact factor: 4.432

7.  Transport of dibromosulphthalein by isolated rat hepatocytes.

Authors:  A Blom; K Keulemans; D K Meijer
Journal:  Biochem Pharmacol       Date:  1981-07-01       Impact factor: 5.858

8.  Hepatic and renal disposition of pancuronium and gallamine in patients with extrahepatic cholestasis.

Authors:  P Westra; G A Vermeer; A R de Lange; A H Scaf; D K Meijer; H Wesseling
Journal:  Br J Anaesth       Date:  1981-04       Impact factor: 9.166

Review 9.  Biliary excretion of drugs in man.

Authors:  D E Rollins; C D Klaassen
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

10.  Influence of bile salts on hepatic transport of dibromosulphthalein.

Authors:  R J Vonk; M Danhof; T Coenraads; A B van Doorn; K Keulemans; A H Scaf; D K Meijer
Journal:  Am J Physiol       Date:  1979-12
View more
  7 in total

1.  Minimal biliary excretion and enterohepatic recirculation of metoclopramide in patients with extrahepatic cholestasis.

Authors:  A Hellstern; D Hellenbrecht; R Saller; M Gatzen; G Achtert; P Brockmann; H J Hausleiter
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

2.  Pharmacokinetics of biliary excretion of N-nitrosodimethylamine in rats fed diets containing levels of protein.

Authors:  F O Alaneme; E N Maduagwu
Journal:  Malawi Med J       Date:  2004-03       Impact factor: 0.875

3.  Formation of a metabolite of dibromosulfophthalein (DBSP) in man.

Authors:  D K Meijer; J G Weitering; B L Bajema; G A Vermeer
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Pharmacokinetics of biliary excretion in man. VI. Indocyanine green.

Authors:  D K Meijer; B Weert; G A Vermeer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy.

Authors:  D Terziivanov; Z Gerova; V Vlahov; A Merdzhanov; D Damjanov
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Biliary elimination of indomethacin in man.

Authors:  B Terhaag; U Hermann
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Dibromosulphophthalein: its pharmacokinetics and binding to hepatic cytosol proteins in rats with acute renal failure.

Authors:  D J Silberstein; C J Bowmer; M S Yates
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.